公司资料
Longboard Pharmaceuticals 股价、新闻与催化剂
- 股票代码:
- LBPH
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股价为何变动
Current closing-price context is not available for LBPH.
公司概览
业务概览
Longboard Pharmaceuticals was a neuroscience company focused on epilepsy and neurological disorders before being acquired by Lundbeck. Its story centered on a targeted CNS asset and clinical differentiation.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ prior to acquisition, Longboard sat in specialty neuroscience biotechnology.
商业模式特征
The business depended on clinical data, CNS differentiation, and the strategic value of its pipeline.
生物医药行业定位
Longboard was a focused neuroscience catalyst name and now belongs to biotech M&A history.
未来催化剂
- Longboard’s catalyst is bexicaserin in pediatric and rare epilepsies, with dose and efficacy updates doing most of the work. The company is still very much a one-program story.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。